BioCentury
ARTICLE | Company News

RXi Pharmaceuticals management update

August 31, 2009 7:00 AM UTC

RXi Pharmaceuticals Corp. (NASDAQ:RXII), Worcester, Mass. Business: Inflammation, Metabolic Resigned: Stephen DiPalma as EVP of business operations and CFO ...